“EVALUATING THE HATCH-WAXMAN AMENDMENT’S INFLUENCE ON FDA’S GENERIC MEDICATION APPROVAL PROCESS” (2022) Journal of Pharmaceutical Negative Results, pp. 3393–3405. doi:10.47750/pnr.2022.13.S06.454.